Reversible optic neuropathy with OPA1 exon 5b mutation

Annals of Neurology

Volumn 63, Issue 5, 2008, Pages 667-671

  Cornille, Karen ^a   Milea, Dan ^b   Amati Bonneau, Patrizia ^c   Procaccio, Vincent ^d   Zazoun, Lydie ^e   Guillet, Virginie ^c   El Achouri, Ghizlane ^a   Delettre, Cécile ^a   Gueguen, Naïg ^c   Loiseau, Dominique ^c   Muller, Agnès ^a   Ferré, Marc ^c   Chevrollier, Arnaud ^c   Wallace, Douglas C ^d   Bonneau, Dominique ^c   Hamel, Christian ^a   Reynier, Pascal ^c   Lenaers, Guy ^a,f  

^a INSERM   (France)

^b Mental Health Services CPH   (Denmark)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Cabinet d'Ophtalmologie   (France)

^f Montpellier University Medical Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OPTIC NERVE DISEASE; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; GENETIC PREDISPOSITION; GENETICS; MALE; MUTATION;

GUANOSINE TRIPHOSPHATASE; OPA1 PROTEIN, HUMAN;

ADULT; EXONS; GENETIC PREDISPOSITION TO DISEASE; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MUTATION; OPTIC NERVE DISEASES;

EID: 44849143066     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21376     Document Type: Article

References (21)

1. Carelli V, La Morgia C, Iommarini L, et al. Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci Rep 2007;27:173-184.
2. Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol 2005;140:517-523.
3. Nikoskelainen EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996;103:504-514.
4. Mackey DA. Three subgroups of patients from the United Kingdom with Leber hereditary optic neuropathy. Eye 1994;8(pt 4):431-436.
5. Acaroglu G, Kansu T, Dogulu CF. Visual recovery patterns in children with Leber's hereditary optic neuropathy. Int Ophthalmol 2001;24:349-355.
6. Brown J Jr, Fingert JH, Taylor CM, et al. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1). Arch Ophthalmol 1997;115:95-99.
7. Votruba M, Moore AT, Bhattacharya SS. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet 1998;35:793-800.
8. Votruba M. Molecular genetic basis of primary inherited optic neuropathies. Eye 2004;18:1126-1132.
9. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-210.
10. Reynier P, Amati-Bonneau P, Verny C, et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet 2004;41:e110.
11. Ferre M, Amati-Bonneau P, Tourmen Y, et al. eOPA1: an online database for OPA1 mutations. Hum Mutat 2005;25:423-428.
12. Olichon A, Elachouri G, Baricault L, et al. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ 2007;14:682-692.
13. Baris O, Delettre C, Amati-Bonneau P, et al. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat 2003;21:656.
14. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003;278:7743-7746.
15. Loiseau D, Chevrollier A, Verny C, et al. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol 2007;61:315-323.
16. Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
17. Ouhabi R, Boue-Grabot M, Mazat JP. Mitochondrial ATP synthesis in permeabilized cells: assessment of the ATP/O values in situ. Anal Biochem 1998;263:169-175.
18. Delettre C, Griffoin JM, Kaplan J, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 2001;109:584-591.
19. Amati-Bonneau P, Guichet A, Olichon A, et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol 2005;58:958-963.
20. Olichon A, Landes T, Arnaune-Pelloquin L, et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 2007;211:423-430.
21. Duvezin-Caubet S, Jagasia R, Wagener J, et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006;281:37972-37979.